US › Healthcare

Alpha Cognition Inc (ACOG)

US · Healthcare · Biotechnology

$8.94+6.05%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$3.5M
Revenue YoY
+20.7%
Net profit
$-6.5M
Profit YoY
-222.8%
EPS
$-0.32
EPS estimate
$-0.39
Net margin
-183.3%

EPS came in at -0.32 against a street estimate of -0.39 — a beat of 17.9%.

Key statistics

Market cap
$180.3M
Forward P/E
26.9
P/B
3.15
Book value
$2.64
EPS (TTM)
$-1.39
52-week high
$10.10
52-week low
$4.50
50-day MA
$7.12
200-day MA
$6.27
Beta
2.33

Analyst view

Analysts rate Alpha Cognition Inc a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $16.00.

Shareholding

Insiders
5.28%
Institutions
55.06%

Largest institutional holders

FundStake
Opaleye Management Inc11.77%
Solas Capital Management LLC8.84%
Awm Investment Company Inc7.68%
Cable Car Capital LLC6.35%
Ikarian Capital, LLC4.85%
Sphera Funds Management Ltd.2.61%
Alyeska Investment Group, L.P.1.68%
BOOTHBAY FUND MANAGEMENT, LLC1.18%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Alpha Cognition Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.